wound cesarean. Maternal care due to uterine scar from previous surgery
Conditions
Interventions
Intervention 1: The first intervention group will receive 5 mg / d of Dexmedetomidine and 10 mg of Hyperbaric marcaine 0.5%. Intervention 2: The second intervention group will receive 5mg of sufentani
Treatment - Drugs
The first intervention group will receive 5 mg / d of Dexmedetomidine and 10 mg of Hyperbaric marcaine 0.5%.
The second intervention group will receive 5mg of sufentanil with 10mg of hyperbaric marcaine 0.5%
Sponsors
Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: singleton, 18 to 45 years term pregnant women with a body mass of 18 to 30 with ASA class 1 candidate for cesarean section Exclusion criteria: Having any underlying disease such as cardiovascular disease (IHD cardiomyopathy), pre-eclampsia, Hypertension; neurological diseases such as migraine; Psychiatric diseases; History of allergy to local anesthesia; Emergency cesarean surgery; Cases requiring general anesthesia during surgery.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Painless. Timepoint: At the time of 1, 2, 4, 6, 8, 10, 12, 16, 20 and 24 hours after the end of surgery. Method of measurement: Question from patient and visual observation (VAS).;Headache. Timepoint: At the time of 1, 2, 4, 6, 8, 10, 12, 16, 20 and 24 hours after the end of surgery. Method of measurement: Question from patient and visual observation (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahrokh Alikhani
Kermanshah University of Medical Sciences
Outcome results
None listed